SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM’S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES
By asianet
TOT BIOPHARM International Company Limited (TOT BIOPHARM, Stock code: 1875.HK) has recently received a GMP compliance inspection report approved by a Qualified Person (“QP”) in the European Union (“EU”) in respect of the manufacturing facilities and associated quality systems of the Group’s commercial production base for its self-developed HER2-targeted antibody drug conjugate (“ADC”) candidate, TAA013. … Continued